Advertisement

Decreased ProBDNF: The Cause of Alzheimer’s-Associated Neurodegeneration and Cognitive Decline?

  • Margaret Fahnestock
  • S. Peng
  • D.J. Garzon
  • Elliott J. Mufson
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 57)

Keywords

Mildly Cognitively Impaired Brain Derive Neurotrophic Factor Brain Derive Neurotrophic Factor Level Brain Derive Neurotrophic Factor Expression Brain Derive Neurotrophic Factor mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hofer M, Pagliusi SR, Hohn A, et al. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990;9(8):2459–2464 .PubMedGoogle Scholar
  2. 2.
    Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225(4667):1168–1170.PubMedCrossRefGoogle Scholar
  3. 3.
    DiStefano PS, Friedman B, Radziejewski C, et al. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992;8(5):983–993.PubMedCrossRefGoogle Scholar
  4. 4.
    Knusel B, Beck KD, Winslow JW, et al. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 1992;12(11):4391–4402.PubMedGoogle Scholar
  5. 5.
    Ando S, Kobayashi S, Waki H, et al. Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J Neurosci Res 2002;70(3):519–527.PubMedCrossRefGoogle Scholar
  6. 6.
    Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994;263(5153):1618–1623.PubMedCrossRefGoogle Scholar
  7. 7.
    Lowenstein DH, Arsenault L. The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons. J Neurosci 1996;16(5):1759–1769.PubMedGoogle Scholar
  8. 8.
    Kohara K, Kitamura A, Morishima M, Tsumoto T. Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 2001;291(5512):2419–2423.PubMedCrossRefGoogle Scholar
  9. 9.
    Lindholm D, Carroll P, Tzimagiogis G, Thoenen H. Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4. Eur J Neurosci 1996;8(7):1452–460.PubMedCrossRefGoogle Scholar
  10. 10.
    Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995;267(5204):1658–1662.PubMedCrossRefGoogle Scholar
  11. 11.
    Korte M, Kang H, Bonhoeffer T, Schuman E. A role for BDNF in the late-phase of hippocampal long-term potentiation. Neuropharmacology 1998;37(4-5):553–559.PubMedCrossRefGoogle Scholar
  12. 12.
    Mcallister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci 1999;22:295–318.PubMedCrossRefGoogle Scholar
  13. 13.
    Broad KD, Mimmack ML, Keverne EB, Kendrick KM. Increased BDNF and trk-B mRNA expression in cortical and limbic regions following formation of a social recognition memory. Eur J Neurosci 2002;16(11):2166–2174.PubMedCrossRefGoogle Scholar
  14. 14.
    Hariri AR, Goldberg TE, Mattay VS, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003;23(17):6690–6694.PubMedGoogle Scholar
  15. 15.
    Mowla SJ, Farhadi HF, Pareek S, et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001;276(16):12660–12666.PubMedCrossRefGoogle Scholar
  16. 16.
    Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001;294(5548):1945–1948.PubMedCrossRefGoogle Scholar
  17. 17.
    Chen ZY, Patel PD, Sant G, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004;24(18):4401–4411.PubMedCrossRefGoogle Scholar
  18. 18.
    Pang PT, Teng HK, Zaitsev E, et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004;306(5695):487–491.PubMedCrossRefGoogle Scholar
  19. 19.
    Seidah NG, Benjannet S, Pareek S, et al. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett 1996;379(3):247–250.PubMedCrossRefGoogle Scholar
  20. 20.
    Fayard B, Loeffler S, Weis J, et al. The secreted brain-derived neurotrophic factor precursor pro-BDNF binds to TrkB and p75NTR but not to TrkA or TrkC. J Neurosci Res 2005;80(1):18–28.PubMedCrossRefGoogle Scholar
  21. 21.
    Michalski B, Fahnestock M. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 2003;111(1-2):148–154.PubMedCrossRefGoogle Scholar
  22. 22.
    DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990;27(5):457–464.PubMedCrossRefGoogle Scholar
  23. 23.
    Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30(4):572–580.PubMedCrossRefGoogle Scholar
  24. 24.
    Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 2004;63(7):1155–1162.PubMedGoogle Scholar
  25. 25.
    Holsinger RM, Schnarr J, Henry P, et al. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 2000;76(2):347–354.PubMedCrossRefGoogle Scholar
  26. 26.
    Phillips HS, Hains JM, Armanini M, et al., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron (1991)7(5), 695–702.PubMedCrossRefGoogle Scholar
  27. 27.
    Fahnestock M, Garzon D, Holsinger RM, Michalski B. Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? J Neural Transm Suppl 2002;62:241–252.PubMedGoogle Scholar
  28. 28.
    Ferrer I, Marin C, Rey MJ, et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease: implications in therapeutic strategies. J Neuropathol Exp Neurol 1999;58(7):729–739.PubMedCrossRefGoogle Scholar
  29. 29.
    Peng S, Wuu J, Mufson EJ, Fahnestock M. ProBDNF and mature BDNF are decreased in the preclinical stages of Alzheimer’s disease. J Neurochem 2005;93(6):1412–1421.PubMedCrossRefGoogle Scholar
  30. 30.
    Aoyama M, Asai K, Shishikura T, et al. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001;164(1):51–60.PubMedCrossRefGoogle Scholar
  31. 31.
    Garzon D, Yu G, Fahnestock M. A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem 2002;82(5):1058–1064.PubMedCrossRefGoogle Scholar
  32. 32.
    Liu QR, Walther D, Drgon T, et al. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2005;134(1):93–103.PubMedGoogle Scholar
  33. 33.
    Sommer B. Alzheimer's disease and the amyloid cascade hypothesis: ten years on. Curr Opin Pharmacol 2002;.2(1):87–92.PubMedCrossRefGoogle Scholar
  34. 34.
    Garzon D, Fahnestock M. Transcriptional down-regulation of BDNF by oligomeric amyloid-beta application to human neuroblastoma cells. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2005. Online.Google Scholar
  35. 35.
    Patterson SL, Abel T, Deuel TA, et al., Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996;16(6):1137–1145.PubMedCrossRefGoogle Scholar
  36. 36.
    Bartoletti A, Cancedda L, Reid SW, et al. Heterozygous knock-out mice for brain-derived neurotrophic factor show a pathway-specific impairment of long-term potentiation but normal critical period for monocular deprivation. J Neurosci 2002;22(23):10072–10077.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Margaret Fahnestock
    • 1
  • S. Peng
  • D.J. Garzon
  • Elliott J. Mufson
  1. 1.Department of Psychiatry and Behavioural NeurosciencesMcMaster UniversityCanada

Personalised recommendations